BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dexrazoxane: Referral procedure for clarification of a potentially increased risk of secondary cancers

Active substance: dexrazoxane

In the course of a graduated plan procedure, stage II, the BfArM announces the initiation of a referral procedure in accordance with Article 31 of Directive 2001/83/EC.

risk information - full text (available in German only)